Shiraishi Chihiro (Chihiro Shiraishi)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Drug Administration

Molecular Dynamics

Top Venues

Clinical drug investigation

Journal of biopharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Shiraishi Chihiro, Toshinori Hirai, Michiko Kaneda, Akiharu Okamoto, Hideo Kato, Kayo Tanaka, Eiji Kondo, Tomoaki Ikeda, Takuya Iwamoto
Factors for the development of anemia in patients with newly introduced olaparib: A retrospective case-control study. Medicine 102 (30) (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation (2023)
Toru Ogura, Shiraishi Chihiro
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System. Clinical drug investigation 43 (2) (2023)
Toru Ogura, Shiraishi Chihiro
Parameter estimation of Weibull distribution for the number of days between drug administration and early onset adverse event. Journal of biopharmaceutical statistics (2022)